Makes sense. People flocked to the safe haven of gold when we were in the midst of a pandemic, but now that we see the light at the end of the tunnel, it's time to get out.
It seems to me, once the truth came out, it was BETTER news. Due to an error, a smaller group of test subjects accidentally received an initial half dose, instead of a full dose. But those individuals ended up with 90% efficacy. Far better than the 62% efficacy from the other participants that had the full dose (and the 70% average that they advertised). Now they will redo the trial, but this time will intentionally use a half dose. The result should be 90% efficacy.
@[Shareholders Unite](user:38036), you are a bit of an expert on Medigus/Scoutcam, right? Were you aware of these non-medical uses for it? This could greatly increase it's revenue potential. Complete news to me!
Latest Comments
Is This The Beginning Of Another Commodities Supercycle?
Yes, it is.
A Rally For The History Books
Good to see you back here Troy, it's been a while.
Oil Prices Edge Past $45
Great read, thanks.
This Should Concern All Tesla Stock Bulls
Rereading this, don't you think they are talking about the single motor 40k cybertruck? Which yes... has been expected for 2023. $TSLA
Gold Drifts To Worst Monthly Decline On Vaccine Hopes
Makes sense. People flocked to the safe haven of gold when we were in the midst of a pandemic, but now that we see the light at the end of the tunnel, it's time to get out.
Good Day For Bad News
It seems to me, once the truth came out, it was BETTER news. Due to an error, a smaller group of test subjects accidentally received an initial half dose, instead of a full dose. But those individuals ended up with 90% efficacy. Far better than the 62% efficacy from the other participants that had the full dose (and the 70% average that they advertised). Now they will redo the trial, but this time will intentionally use a half dose. The result should be 90% efficacy.
Medigus Is Facing Multiple Opportunities But Is Not Without Risk
I thought this article that just came out today shows some additional potential for $MDGS / $SCTC
talkmarkets.com/.../the-electric-vehicle-space-has-shown-amazing-lockdown-resilience
The Electric Vehicle Space Has Shown Amazing Lockdown Resilience
@[Shareholders Unite](user:38036), you are a bit of an expert on Medigus/Scoutcam, right? Were you aware of these non-medical uses for it? This could greatly increase it's revenue potential. Complete news to me!
Judy Shelton - Thank You; Janet Yellen - She's Back
I think Yellen was a strong choice.
Piper Boosts Moderna Target To $166 After 'Impressive' Vaccine Response
Unless one of the other countless pharma companies working on a vaccine comes out with something better and cheaper tomorrow.